These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9186170)

  • 1. Interaction of thyroxine sodium with antimalarial drugs.
    Munera Y; Hugues FC; Le Jeunne C; Pays JF
    BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186170
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil.
    Wielgo-Polanin R; Lagarce L; Gautron E; Diquet B; Lainé-Cessac P
    Int J Antimicrob Agents; 2005 Aug; 26(2):176-8. PubMed ID: 16009537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil.
    Janier M; Froidevaux D; Lons-Danic D; Daniel F
    Dermatology; 1998; 196(2):271. PubMed ID: 9568425
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability of doxycycline monohydrate salt vs. chloroquine-proguanil in malaria chemoprophylaxis.
    Pagès F; Boutin JP; Meynard JB; Keundjian A; Ryfer S; Giurato L; Baudon D
    Trop Med Int Health; 2002 Nov; 7(11):919-24. PubMed ID: 12390596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic effect of Malarone against malaria: all good news?
    Nosten F
    Lancet; 2000 Dec; 356(9245):1864-5. PubMed ID: 11130375
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe mucocutaneous necrotizing vasculitis associated with the combination of chloroquine and proguanil.
    Luong MS; Bessis D; Raison-Peyron N; Pinzani V; Guilhou JJ; Guillot B
    Acta Derm Venereol; 2003; 83(2):141. PubMed ID: 12735648
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
    Barrett PJ; Emmins PD; Clarke PD; Bradley DJ
    BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
    Davis TM
    Ann Pharmacother; 1998 Oct; 32(10):1104-6. PubMed ID: 9793605
    [No Abstract]   [Full Text] [Related]  

  • 11. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Duodenal ulcers caused by chloroquine-proguanil association].
    Roux X; Imbert P; Rivière F; Méchaï F; Rapp C
    Med Trop (Mars); 2010 Dec; 70(5-6):423-4. PubMed ID: 21520638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
    Angles A; Bagheri H; Montastruc JL; Magnaval JF;
    Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
    Kamaliddin C; Joste V; Argy N; Houzé S
    Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
    [No Abstract]   [Full Text] [Related]  

  • 15. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK; Parise ME; Lewis LS; Kain KC
    Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of antimalarials in patients with renal failure.
    Thorogood N; Atwal S; Mills W; Jenner M; Lewis DA; Cavenagh JD; Agrawal SG
    Postgrad Med J; 2007 Dec; 83(986):e8. PubMed ID: 18057166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema multiforme and Malarone(®).
    Becher G; Wylie G
    Travel Med Infect Dis; 2012 Sep; 10(5-6):279-80. PubMed ID: 22951669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.